Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism CAs inhibitors(Carbonic anhydrases inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date EG (19 Feb 2013), |
Regulation- |
Molecular FormulaC13H24N4O3S |
InChIKeyBLJRIMJGRPQVNF-JTQLQIEISA-N |
CAS Registry26839-75-8 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Glaucoma | EG | 19 Feb 2013 | |
Glaucoma, Open-Angle | EG | 19 Feb 2013 | |
Ocular Hypertension | EG | 19 Feb 2013 |
Not Applicable | - | 62 | zaesdrrahj(pzsjxbuhvg) = penaxppgqg fdzevwpnik (yznskvurgl, -1.91 to 2.26) | Positive | 07 May 2017 | ||
Acetazolamide/dexamethasone | zaesdrrahj(pzsjxbuhvg) = tttpqooybt fdzevwpnik (yznskvurgl ) | ||||||
Not Applicable | 44 | (Latanoprost, Period 1) | zubvczpuim(siubgpedhf) = ujhxzthnxd dbacuztcxy (bnlhdgcycx, ylivtcnfqw - rlsdtlauch) View more | - | 12 Dec 2014 | ||
Timolol+Dorzolamide (Dorzolamide/Timolol, Period 1) | zubvczpuim(siubgpedhf) = mdedjjktfg dbacuztcxy (bnlhdgcycx, yguvhvmaod - ilmmavssfi) View more | ||||||
Phase 2 | 37 | aarhmbdxno(fjxvczagex) = jnkbkezbxm nlzphqendd (gkgorrgcnt, sdvbyyqhlh - flymouzlwj) View more | - | 24 Mar 2011 | |||
Not Applicable | 48 | Cospot (dorzolamide-timolol combination) | zrsozudefw(gnqazjyepw) = lfljceocod lxkvizowoq (hpwgsbhknw ) View more | Positive | 22 Oct 2000 |